Cellular and Molecular Gastroenterology and Hepatology (Jan 2022)

cccDNA Surrogate MC-HBV–Based Screen Identifies Cohesin Complex as a Novel HBV Restriction FactorSummary

  • Zhuanchang Wu,
  • Liyuan Wang,
  • Xin Wang,
  • Yang Sun,
  • Haoran Li,
  • Zhaoying Zhang,
  • Caiyue Ren,
  • Xiaohui Zhang,
  • Shuangjie Li,
  • Jinghui Lu,
  • Leiqi Xu,
  • Xuetian Yue,
  • Yue Hong,
  • Qiang Li,
  • Haizhen Zhu,
  • Yaoqin Gong,
  • Chengjiang Gao,
  • Huili Hu,
  • Lifen Gao,
  • Xiaohong Liang,
  • Chunhong Ma

Journal volume & issue
Vol. 14, no. 6
pp. 1177 – 1198

Abstract

Read online

Background & Aims: Covalently closed circular DNA (cccDNA) of hepatitis B virus (HBV), existing as a stable minichromosome in the hepatocyte, is responsible for persistent HBV infection. Maintenance and sustained replication of cccDNA require its interaction with both viral and host proteins. However, the cccDNA-interacting host factors that limit HBV replication remain elusive. Methods: Minicircle HBV (MC-HBV), a recombinant cccDNA, was constructed based on chimeric intron and minicircle DNA technology. By mass spectrometry based on pull-down with biotinylated MC-HBV, the cccDNA-hepatocyte interaction profile was mapped. HBV replication was assessed in different cell models that support cccDNA formation. Results: MC-HBV supports persistent HBV replication and mimics the cccDNA minichromosome. The MC-HBV–based screen identified cohesin complex as a cccDNA binding host factor, leading to reduced HBV replication. Mechanistically, with the help of CCCTC-binding factor (CTCF), which has specific binding sites on cccDNA, cohesin loads on cccDNA and reshapes cccDNA confirmation to prevent RNA polymerase II enrichment. Interestingly, HBV X protein transcriptionally reduces structural maintenance of chromosomes complex expression to partially relieve the inhibitory role of the cohesin complex on HBV replication. Conclusions: Our data not only provide a feasible approach to explore cccDNA-binding factors, but also identify cohesin/CTCF complex as a critical host restriction factor for cccDNA-driven HBV replication. These findings provide a novel insight into cccDNA–host interaction and targeted therapeutic intervention for HBV infection.

Keywords